Ro 40–5967: A New Nondihydropyridine Calcium Antagonist

This publication has 21 references indexed in Scilit:

• The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts
  Cardiovascular Drugs and Therapy, 1990
• Effects of Ro 40-5967, a Novel Calcium Antagonist, on Myocardial Function During Ischemia Induced by Lowering Coronary Perfusion Pressure in Dogs: Comparison with Verapamil
  Journal of Cardiovascular Pharmacology, 1989
• The Effect of Diltiazem on Mortality and Reinfarction after Myocardial Infarction
  New England Journal of Medicine, 1988
• Gingival Hyperplasia in Dogs Induced by Oxodipine, a Calcium Channel Blocking Agent
  Toxicologic Pathology, 1988
• Pharmacokinetics and Pharmacodynamic Effects of Aqueous Diltiazem in Healthy Humans
  The Journal of Clinical Pharmacology, 1987
• (—)‐[³H]Desmethoxyverapamil, a novel Ca²⁺ channel probe
  FEBS Letters, 1984
• Gingival hyperplasia caused by nifedipine — a preliminary report
  International Journal of Cardiology, 1984
• Calcium-channel blockers: Pharmacologic considerations
  American Heart Journal, 1982
• Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease
  The American Journal of Cardiology, 1981
• Regional contractility. Selective depression of ischemic myocardium by verapamil.
  Circulation, 1976